{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T15:56:14Z","timestamp":1793894174161,"version":"4.8.0"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T00:00:00Z","timestamp":1589500800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T00:00:00Z","timestamp":1589500800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology","doi-asserted-by":"publisher","award":["IF: 150273"],"award-info":[{"award-number":["IF: 150273"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s13346-020-00772-x","type":"journal-article","created":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T16:04:53Z","timestamp":1589558693000},"page":"839-861","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Supersaturated LFCS type III self-emulsifying delivery systems of sorafenib tosylate with improved biopharmaceutical performance: QbD-enabled development and evaluation"],"prefix":"10.1007","volume":"10","author":[{"given":"Teenu","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atul","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranjot","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumant","family":"Saini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O P","family":"Katare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhupinder","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,15]]},"reference":[{"key":"772_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/jcar.JCar_9_16","volume":"16","author":"YA Ghouri","year":"2017","unstructured":"Ghouri YA, Mian I, Rowe JH. Review of hepatocellular carcinoma: epidemiology, etiology, and carcinogenesis. J Carcinog. 2017;16:1\u201313.","journal-title":"J Carcinog"},{"key":"772_CR2","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/hep.27388","volume":"61","author":"B Njei","year":"2015","unstructured":"Njei B, Rotman Y, Ditah I, Lim JK. Emerging trends in hepatocellular carcinoma incidence and mortality. Hepatology. 2015;61:191\u20139.","journal-title":"Hepatology."},{"key":"772_CR3","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1172\/JCI76094","volume":"125","author":"S Gross","year":"2015","unstructured":"Gross S, Rahal R, Stransky N, Lengauer C, Hoeflich KP. Targeting cancer with kinase inhibitors. J Clin Invest. 2015;125:1780\u20139.","journal-title":"J Clin Invest"},{"key":"772_CR4","unstructured":"PubChem D. National center for biotechnology information. Sorafenib tosylateCID=406563,. 2019."},{"key":"772_CR5","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1080\/14728214.2017.1336538","volume":"22","author":"L de Rosamel","year":"2017","unstructured":"de Rosamel L, Blanc J-F. Emerging tyrosine kinase inhibitors for the treatment of hepatocellular carcinoma. Expert Opin Emerg Drugs. 2017;22:175\u201390.","journal-title":"Expert Opin Emerg Drugs"},{"key":"772_CR6","first-page":"2329","volume":"11","author":"S Yang","year":"2016","unstructured":"Yang S, Zhang B, Gong X, Wang T, Liu Y, Zhang N. In vivo biodistribution, biocompatibility, and efficacy of sorafenib-loaded lipid-based nanosuspensions evaluated experimentally in cancer. Int J Nanomedicine. 2016;11:2329\u201343.","journal-title":"Int J Nanomedicine"},{"key":"772_CR7","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/s10637-017-0538-9","volume":"36","author":"V Giglio","year":"2018","unstructured":"Giglio V, Viale M, Bertone V, Maric I, Vaccarone R, Vecchio G. Cyclodextrin polymers as nanocarriers for sorafenib. Investig New Drugs. 2018;36:370\u20139.","journal-title":"Investig New Drugs"},{"key":"772_CR8","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ijpharm.2011.08.003","volume":"419","author":"X-q Wang","year":"2011","unstructured":"Wang X-q, J-m F, Y-o L, Zhao B, Jia Z-r, Zhang Q. Bioavailability and pharmacokinetics of sorafenib suspension, nanoparticles and nanomatrix for oral administration to rat. Int J Pharm. 2011;419:339\u201346.","journal-title":"Int J Pharm"},{"key":"772_CR9","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/1556-276X-7-91","volume":"7","author":"DH Kim","year":"2012","unstructured":"Kim DH, Kim M-D, Choi C-W, Chung C-W, Ha SH, Kim CH, et al. Antitumor activity of sorafenib-incorporated nanoparticles of dextran\/poly (dl-lactide-co-glycolide) block copolymer. Nanoscale Res Lett. 2012;7:91\u20136.","journal-title":"Nanoscale Res Lett"},{"key":"772_CR10","doi-asserted-by":"crossref","first-page":"20360","DOI":"10.1021\/acsami.5b06203","volume":"7","author":"RK Thapa","year":"2015","unstructured":"Thapa RK, Choi JY, Poudel BK, Hiep TT, Pathak S, Gupta B, et al. Multilayer-coated liquid crystalline nanoparticles for effective sorafenib delivery to hepatocellular carcinoma. ACS Appl Mater Interfaces. 2015;7:20360\u20138.","journal-title":"ACS Appl Mater Interfaces"},{"key":"772_CR11","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.powtec.2015.04.044","volume":"283","author":"DH Truong","year":"2015","unstructured":"Truong DH, Tran TH, Ramasamy T, Choi JY, Choi HG, Yong CS, et al. Preparation and characterization of solid dispersion using a novel amphiphilic copolymer to enhance dissolution and oral bioavailability of sorafenib. Powder Technol. 2015;283:260\u20135.","journal-title":"Powder Technol"},{"key":"772_CR12","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1016\/j.biomaterials.2014.02.024","volume":"35","author":"Z Zhang","year":"2014","unstructured":"Zhang Z, Niu B, Chen J, He X, Bao X, Zhu J, et al. The use of lipid-coated nanodiamond to improve bioavailability and efficacy of sorafenib in resisting metastasis of gastric cancer. Biomaterials. 2014;35:4565\u201372.","journal-title":"Biomaterials."},{"key":"772_CR13","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.2147\/IJN.S32415","volume":"7","author":"H Zhang","year":"2012","unstructured":"Zhang H, Zhang F-M, Yan S-J. Preparation, in vitro release, and pharmacokinetics in rabbits of lyophilized injection of sorafenib solid lipid nanoparticles. Int J Nanomedicine. 2012;7:2901\u201310.","journal-title":"Int J Nanomedicine"},{"key":"772_CR14","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1002\/adhm.201500235","volume":"4","author":"A Grillone","year":"2015","unstructured":"Grillone A, Riva ER, Mondini A, Forte C, Calucci L, Innocenti C, et al. Active targeting of sorafenib: preparation, characterization, and in vitro testing of drug loaded magnetic solid lipid nanoparticles. Adv Healthc Mater. 2015;4:1681\u201390.","journal-title":"Adv Healthc Mater"},{"key":"772_CR15","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ijpharm.2015.07.055","volume":"493","author":"ML Bond\u00ec","year":"2015","unstructured":"Bond\u00ec ML, Botto C, Amore E, Emma MR, Augello G, Craparo EF, et al. Lipid nanocarriers containing sorafenib inhibit colonies formation in human hepatocarcinoma cells. Int J Pharm. 2015;493:75\u201385.","journal-title":"Int J Pharm"},{"key":"772_CR16","first-page":"1397","volume":"12","author":"WH Fan","year":"2012","unstructured":"Fan WH, Wang XQ. Self-microemulsifying drug delivery system used to improve the oral absorption of sorafenib. Chinese J New Drugs. 2012;12:1397\u2013400.","journal-title":"Chinese J New Drugs"},{"key":"772_CR17","doi-asserted-by":"crossref","first-page":"4479","DOI":"10.2147\/IJN.S103344","volume":"11","author":"DS Pellosi","year":"2016","unstructured":"Pellosi DS, Moret F, Fraix A, Marino N, Maiolino S, Gaio E, et al. Pluronic\u00ae P123\/F127 mixed micelles delivering sorafenib and its combination with verteporfin in cancer cells. Int J Nanomedicine. 2016;11:4479\u201394.","journal-title":"Int J Nanomedicine"},{"key":"772_CR18","doi-asserted-by":"crossref","first-page":"675","DOI":"10.3109\/10717544.2014.896058","volume":"22","author":"S Dokania","year":"2015","unstructured":"Dokania S, Joshi AK. Self-microemulsifying drug delivery system (SMEDDS)\u2013challenges and road ahead. Drug Deliv. 2015;22:675\u201390.","journal-title":"Drug Deliv"},{"key":"772_CR19","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1007\/s11095-013-1063-y","volume":"30","author":"A Elgart","year":"2013","unstructured":"Elgart A, Cherniakov I, Aldouby Y, Domb AJ, Hoffman A. Improved oral bioavailability of BCS class 2 compounds by self nano-emulsifying drug delivery systems (SNEDDS): the underlying mechanisms for amiodarone and talinolol. Pharm Res. 2013;30:3029\u201344.","journal-title":"Pharm Res"},{"key":"772_CR20","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1111\/j.2042-7158.2010.01107.x","volume":"62","author":"A M\u00fcllertz","year":"2010","unstructured":"M\u00fcllertz A, Ogbonna A, Ren S, Rades T. New perspectives on lipid and surfactant based drug delivery systems for oral delivery of poorly soluble drugs. J Pharm Pharmacol. 2010;62:1622\u201336.","journal-title":"J Pharm Pharmacol"},{"key":"772_CR21","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1080\/03639045.2017.1342654","volume":"43","author":"R Savla","year":"2017","unstructured":"Savla R, Browne J, Plassat V, Wasan KM, Wasan EK. Review and analysis of FDA approved drugs using lipid-based formulations. Drug Dev Ind Pharm. 2017;43:1743\u201358.","journal-title":"Drug Dev Ind Pharm"},{"key":"772_CR22","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.addr.2007.10.010","volume":"60","author":"CW Pouton","year":"2008","unstructured":"Pouton CW, Porter CJH. Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies. Adv Drug Deliv Rev. 2008;60:625\u201337.","journal-title":"Adv Drug Deliv Rev"},{"key":"772_CR23","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1517\/17425247.3.1.97","volume":"3","author":"P Gao","year":"2006","unstructured":"Gao P, Morozowich W. Development of supersaturatable self-emulsifying drug delivery system formulations for improving the oral absorption of poorly soluble drugs. Expert Opin Drug Deliv. 2006;3:97\u2013110.","journal-title":"Expert Opin Drug Deliv"},{"key":"772_CR24","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1080\/17425247.2016.1218462","volume":"14","author":"FU Rehman","year":"2017","unstructured":"Rehman FU, Shah KU, Shah SU, Khan IU, Khan GM, Khan A. From nanoemulsions to self-nanoemulsions, with recent advances in self-nanoemulsifying drug delivery systems (SNEDDS). Expert Opin Drug Deliv. 2017;14:1325\u201340.","journal-title":"Expert Opin Drug Deliv."},{"key":"772_CR25","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v22.i3.10","volume":"22","author":"B Singh","year":"2005","unstructured":"Singh B, Dahiya M, Saharan V, Ahuja N. Optimizing drug delivery systems using systematic \u201cdesign of experiments.\u201d Part II: retrospect and prospects. Crit Rev Ther Drug Carrier Syst. 2005;22:215\u201394.","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"772_CR26","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1208\/s12249-019-1319-x","volume":"20","author":"S Beg","year":"2019","unstructured":"Beg S, Kaur R, Khurana RK, Rana V, Sharma T, Singh B. QbD-based development of cationic self-nanoemulsifying drug delivery systems of paclitaxel with improved biopharmaceutical attributes. AAPS PharmSciTech. 2019;20:118\u201331.","journal-title":"AAPS PharmSciTech"},{"key":"772_CR27","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1517\/17425247.2014.877885","volume":"11","author":"S Bandyopadhyay","year":"2014","unstructured":"Bandyopadhyay S, Katare OP, Singh B. Development of optimized supersaturable self-nanoemulsifying systems of ezetimibe: effect of polymers and efflux transporters. Expert Opin Drug Deliv. 2014;11:479\u201392.","journal-title":"Expert Opin Drug Deliv"},{"key":"772_CR28","first-page":"1","volume":"1","author":"SS Bharate","year":"2016","unstructured":"Bharate SS, Bharate SB, Bajaj AN. Interactions and incompatibilities of pharmaceutical excipients with active pharmaceutical ingredients: a comprehensive review. J Excipients Food Chemi. 2016;1:1\u201324.","journal-title":"J Excipients Food Chemi"},{"key":"772_CR29","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1517\/17425247.2010.485983","volume":"7","author":"E Bilensoy","year":"2010","unstructured":"Bilensoy E. Cationic nanoparticles for cancer therapy. Expert Opin Drug Deliv. 2010;7:795\u2013809.","journal-title":"Expert Opin Drug Deliv."},{"key":"772_CR30","first-page":"217","volume":"5","author":"RK Garg","year":"2015","unstructured":"Garg RK, Singhvi I. Optimization techniques: an overview for formulation development. Asian J Pharm Res Vol. 2015;5:217\u201321.","journal-title":"Asian J Pharm Res Vol"},{"key":"772_CR31","unstructured":"Commission IP. Indian pharmacopoeia. 2014th ed. New Delhi: GOI; 2014. p. 2775."},{"key":"772_CR32","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s13346-018-0498-4","volume":"8","author":"RK Khurana","year":"2018","unstructured":"Khurana RK, Gaspar BL, Welsby G, Katare OP, Singh KK, Singh B. Improving the biopharmaceutical attributes of mangiferin using vitamin E-TPGS co-loaded self-assembled phosholipidic nano-mixed micellar systems. Drug Deliv Trans Res. 2018;8:617\u201332.","journal-title":"Drug Deliv Trans Res"},{"key":"772_CR33","first-page":"196","volume":"59","author":"B Singh","year":"1997","unstructured":"Singh B, Kaur T, Singh S. Correction of raw dissolution data for loss of drug and volume during sampling. Indian J Pharm Sci. 1997;59:196\u201301.","journal-title":"Indian J Pharm Sci"},{"key":"772_CR34","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.colsurfb.2012.06.031","volume":"101","author":"S Beg","year":"2013","unstructured":"Beg S, Jena SS, Patra CN, Rizwan M, Swain S, Sruti J, et al. Development of solid self-nanoemulsifying granules (SSNEGs) of ondansetron hydrochloride with enhanced bioavailability potential. Colloids Surf B Biointerfaces. 2013;101:414\u201323.","journal-title":"Colloids Surf B Biointerfaces."},{"key":"772_CR35","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1002\/jps.10511","volume":"92","author":"P Gao","year":"2003","unstructured":"Gao P, Rush BD, Pfund WP, Huang T, Bauer JM, Morozowich W, et al. Development of a supersaturable SEDDS (S-SEDDS) formulation of paclitaxel with improved oral bioavailability. J Pharm Sci. 2003;92:2386\u201398.","journal-title":"J Pharm Sci"},{"key":"772_CR36","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1007\/s13346-018-0514-8","volume":"8","author":"A Jain","year":"2018","unstructured":"Jain A, Kaur R, Beg S, Kushwah V, Jain S, Singh B. Novel cationic supersaturable nanomicellar systems of raloxifene hydrochloride with enhanced biopharmaceutical attributes. Drug Deliv Transl Res. 2018;8:670\u201392.","journal-title":"Drug Deliv Transl Res"},{"key":"772_CR37","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0928-0987(01)00095-1","volume":"13","author":"P Costa","year":"2001","unstructured":"Costa P, Lobo JMS. Modeling and comparison of dissolution profiles. Eur J Pharm Sci. 2001;13:123\u201333.","journal-title":"Eur J Pharm Sci"},{"key":"772_CR38","doi-asserted-by":"crossref","unstructured":"Orellana EA, Kasinski AL. Sulforhodamine B (SRB) assay in cell culture to investigate cell proliferation. https:\/\/bio-protocol.org\/e1984. 2016; Acess Date: Dec 2019.","DOI":"10.21769\/BioProtoc.1984"},{"key":"772_CR39","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s11095-013-1213-2","volume":"31","author":"AK Jain","year":"2013","unstructured":"Jain AK, Thanki K, Jain S. Solidified self-nanoemulsifying formulation for oral delivery of combinatorial therapeutic regimen: part I. Formulation development, statistical optimization, and in vitro characterization. Pharm Res. 2013;31:923\u201345.","journal-title":"Pharm Res"},{"key":"772_CR40","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/0976-0105.177703","volume":"7","author":"AB Nair","year":"2016","unstructured":"Nair AB, Jacob S. A simple practice guide for dose conversion between animals and human. J Basic Clin Pharm. 2016;7:27\u201331.","journal-title":"J Basic Clin Pharm"},{"key":"772_CR41","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ejpb.2017.09.001","volume":"121","author":"RK Khurana","year":"2017","unstructured":"Khurana RK, Beg S, Burrow AJ, Vashishta RK, Katare OP, Kaur S, et al. Enhancing biopharmaceutical performance of an anticancer drug by long chain PUFA based self-nanoemulsifying lipidic nanomicellar systems. Eur J Pharm Biopharm. 2017;121:42\u201360.","journal-title":"Eur J Pharm Biopharm"},{"key":"772_CR42","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.4169","volume":"32","author":"T Sharma","year":"2018","unstructured":"Sharma T, Khurana RK, Jain A, Katare OP, Singh B. Development of a validated liquid chromatographic method for quantification of sorafenib tosylate in the presence of stress-induced degradation products and in biological matrix employing analytical quality by design approach. Biomed Chromatogr. 2018;32:e4169.","journal-title":"Biomed Chromatogr"},{"key":"772_CR43","doi-asserted-by":"crossref","first-page":"544","DOI":"10.2174\/1567201812666150227125639","volume":"12","author":"S Bandyopadhyay","year":"2015","unstructured":"Bandyopadhyay S, Beg S, Katare OP, Sharma G, Singh B. QbD-oriented development of self-nanoemulsifying drug delivery systems (SNEDDS) of valsartan with improved biopharmaceutical performance. Curr Drug Deliv. 2015;12:544\u201363.","journal-title":"Curr Drug Deliv"},{"key":"772_CR44","unstructured":"WHO. Stability testing of active pharmaceutical ingredients and finished pharmaceutical products. In: preparations Ecosfp, editor. 2018."},{"key":"772_CR45","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.colsurfb.2012.05.019","volume":"100","author":"S Bandyopadhyay","year":"2012","unstructured":"Bandyopadhyay S, Katare OP, Singh B. Optimized self nano-emulsifying systems of ezetimibe with enhanced bioavailability potential using long chain and medium chain triglycerides. Colloids Surf B Biointerfaces. 2012;100:50\u201361.","journal-title":"Colloids Surf B Biointerfaces."},{"key":"772_CR46","doi-asserted-by":"crossref","unstructured":"Beg S, Sandhu PS, Batra RS, Khurana RK, Singh B. QbD-based systematic development of novel optimized solid self-nanoemulsifying drug delivery systems (SNEDDS) of lovastatin with enhanced biopharmaceutical performance. Drug Deliv. 2014:1\u201320.","DOI":"10.3109\/10717544.2014.900154"},{"key":"772_CR47","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1023\/A:1018984731584","volume":"11","author":"ES Swenson","year":"1994","unstructured":"Swenson ES, Milisen WB, Curatolo W. Intestinal permeability enhancement: efficacy, acute local toxicity, and reversibility. Pharm Res. 1994;11:1132\u201342.","journal-title":"Pharm Res"},{"key":"772_CR48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/541510","volume":"2015","author":"J Wadhwa","year":"2015","unstructured":"Wadhwa J, Asthana A, Shilakari G, Chopra AK, Singh R. Development and evaluation of nanoemulsifying preconcentrate of curcumin for colon delivery. Sci World J. 2015;2015:1\u201313.","journal-title":"Sci World J"},{"key":"772_CR49","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0378-5173(02)00003-0","volume":"235","author":"S Nazzal","year":"2002","unstructured":"Nazzal S, Smalyukh II, Lavrentovich OD, Khan MA. Preparation and in vitro characterization of a eutectic based semisolid self-nanoemulsified drug delivery system (SNEDDS) of ubiquinone: mechanism and progress of emulsion formation. Int J Pharm. 2002;235:247\u201365.","journal-title":"Int J Pharm"},{"key":"772_CR50","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jsps.2014.11.001","volume":"23","author":"AM Avachat","year":"2015","unstructured":"Avachat AM, Patel VG. Self nanoemulsifying drug delivery system of stabilized ellagic acid-phospholipid complex with improved dissolution and permeability. Saudi Pharm J. 2015;23:276\u201389.","journal-title":"Saudi Pharm J"},{"key":"772_CR51","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.drudis.2009.07.010","volume":"14","author":"T Bansal","year":"2009","unstructured":"Bansal T, Akhtar N, Jaggi M, Khar RK, Talegaonkar S. Novel formulation approaches for optimising delivery of anticancer drugs based on P-glycoprotein modulation. Drug Discov Today. 2009;14:1067\u201374.","journal-title":"Drug Discov Today"},{"key":"772_CR52","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1080\/03639040802488089","volume":"35","author":"SX Cui","year":"2009","unstructured":"Cui SX, Nie SF, Li L, Wang CG, Pan WS, Sun JP. Preparation and evaluation of self-microemulsifying drug delivery system containing vinpocetine. Drug Dev Ind Pharm. 2009;35:603\u201311.","journal-title":"Drug Dev Ind Pharm"},{"key":"772_CR53","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1208\/s12249-008-9178-x","volume":"10","author":"A Azeem","year":"2009","unstructured":"Azeem A, Rizwan M, Ahmad FJ, Iqbal Z, Khar RK, Aqil M, et al. Nanoemulsion components screening and selection: a technical note. AAPS PharmSciTech. 2009;10:69\u201376.","journal-title":"AAPS PharmSciTech"},{"key":"772_CR54","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v22.i1.20","volume":"22","author":"B Singh","year":"2005","unstructured":"Singh B, Kumar R, Ahuja N. Optimizing drug delivery systems using systematic \u201cdesign of experiments.\u201d Part I: fundamental aspects. Crit Rev Ther Drug Carrier Syst. 2005;22:27\u2013105.","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"772_CR55","doi-asserted-by":"crossref","first-page":"75","DOI":"10.4103\/2230-973X.82395","volume":"1","author":"B Singh","year":"2011","unstructured":"Singh B, Bhatowa R, Tripathi CB, Kapil R. Developing micro-\/nanoparticulate drug delivery systems using \u201cdesign of experiments\u201d. Int J Pharm Invest. 2011;1:75\u201387.","journal-title":"Int J Pharm Invest"},{"key":"772_CR56","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1080\/03639040600685167","volume":"32","author":"Y El-Malah","year":"2006","unstructured":"El-Malah Y, Nazzal S, Khanfar NM. D-optimal mixture design: optimization of ternary matrix blends for controlled zero-order drug release from oral dosage forms. Drug Dev Ind Pharm. 2006;32:1207\u201318.","journal-title":"Drug Dev Ind Pharm"},{"key":"772_CR57","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1289\/ehp.98106s61373","volume":"106","author":"I Eide","year":"1998","unstructured":"Eide I, Johnsen HG. Mixture design and multivariate analysis in mixture research. Environ Health Perspect. 1998;106:1373\u20136.","journal-title":"Environ Health Perspect"},{"key":"772_CR58","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/j.2042-7158.2011.01442.x","volume":"64","author":"B Singh","year":"2012","unstructured":"Singh B, Garg B, Chaturvedi SC, Arora S, Mandsaurwale R, Kapil R, et al. Formulation development of gastroretentive tablets of lamivudine using the floating-bioadhesive potential of optimized polymer blends. J Pharm Pharmacol. 2012;64:654\u201369.","journal-title":"J Pharm Pharmacol"},{"key":"772_CR59","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1208\/s12249-015-0384-z","volume":"17","author":"B Gupta","year":"2016","unstructured":"Gupta B, Poudel BK, Pathak S, Tak JW, Lee HH, Jeong J-H, et al. Effects of formulation variables on the particle size and drug encapsulation of imatinib-loaded solid lipid nanoparticles. AAPS PharmSciTech. 2016;17:652\u201362.","journal-title":"AAPS PharmSciTech"},{"key":"772_CR60","first-page":"1","volume":"54","author":"FS Abdel-Salam","year":"2016","unstructured":"Abdel-Salam FS, Elkheshen SA, Mahmoud AA, Ammar HO. Diflucortolone valerate loaded solid lipid nanoparticles as a semisolid topical delivery system. Bull Fac Pharm Cairo Univ. 2016;54:1\u20137.","journal-title":"Bull Fac Pharm Cairo Univ"},{"key":"772_CR61","first-page":"1115","volume":"7","author":"ZQ Chen","year":"2012","unstructured":"Chen ZQ, Liu Y, Zhao JH, Wang L, Feng NP. Improved oral bioavailability of poorly water-soluble indirubin by a supersaturatable self-microemulsifying drug delivery system. Int J Nanomedicine. 2012;7:1115\u201325.","journal-title":"Int J Nanomedicine"},{"key":"772_CR62","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.colsurfa.2011.12.025","volume":"396","author":"Y Wei","year":"2012","unstructured":"Wei Y, Ye X, Shang X, Peng X, Bao Q, Liu M, et al. Enhanced oral bioavailability of silybin by a supersaturatable self-emulsifying drug delivery system (S-SEDDS). Coll Surf A: Physicochem Eng Aspects. 2012;396:22\u20138.","journal-title":"Coll Surf A: Physicochem Eng Aspects"},{"key":"772_CR63","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1002\/jps.21650","volume":"98","author":"J Brouwers","year":"2009","unstructured":"Brouwers J, Brewster ME, Augustijns P. Supersaturating drug delivery systems: the answer to solubility-limited oral bioavailability? J Pharm Sci. 2009;98:2549\u201372.","journal-title":"J Pharm Sci"},{"key":"772_CR64","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.ejps.2006.12.003","volume":"30","author":"D Douroumis","year":"2007","unstructured":"Douroumis D, Fahr A. Stable carbamazepine colloidal systems using the cosolvent technique. Eur J Pharm Sci. 2007;30:367\u201374.","journal-title":"Eur J Pharm Sci"},{"key":"772_CR65","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/jps.21451","volume":"98","author":"P Gao","year":"2009","unstructured":"Gao P, Akrami A, Alvarez F, Hu J, Li L, Ma C, et al. Characterization and optimization of AMG 517 supersaturatable self-emulsifying drug delivery system (S-SEDDS) for improved oral absorption. J Pharm Sci. 2009;98:516\u201328.","journal-title":"J Pharm Sci"},{"key":"772_CR66","first-page":"257","volume":"11","author":"Z Nan","year":"2012","unstructured":"Nan Z, Lijun G, Tao W, Dongqin Q. Evaluation of carbamazepine (CBZ) supersaturatable self-microemulsifying (S-SMEDDS) formulation in-vitro and in-vivo. Iran J Pharm Res. 2012;11:257\u201364.","journal-title":"Iran J Pharm Res"},{"key":"772_CR67","doi-asserted-by":"crossref","unstructured":"Singh SK, Verma PR, B Razdan. Development and characterization of a lovastatin-loaded self-microemulsifying drug delivery system. 1;15(5):. Pharm Dev Technol. 2010;469\u2013483.","DOI":"10.3109\/10837450903286537"},{"key":"772_CR68","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.3109\/10717544.2016.1162876","volume":"23","author":"CB Tripathi","year":"2016","unstructured":"Tripathi CB, Beg S, Kaur R, Shukla G, Bandopadhyay S, Singh B. Systematic development of optimized SNEDDS of artemether with improved biopharmaceutical and antimalarial potential. Drug Deliv. 2016;23:3209\u201323.","journal-title":"Drug Deliv."},{"key":"772_CR69","unstructured":"Baoding Hualian Chemical Co. L. Hydroxypropyl methylcellulose (HPMC). http:\/\/www.hualianhg.com\/en\/product. Acess Date: Dec 2019."},{"key":"772_CR70","unstructured":"nanoComposix. Polyvinylpyrrolidone (PVP) Surface. https:\/\/nanocomposix.eu\/pages\/polyvinylpyrrolidone-pvp-surface. Access Date: Dec 2019."},{"key":"772_CR71","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1081\/DDC-120028718","volume":"30","author":"P Gao","year":"2004","unstructured":"Gao P, Guyton ME, Huang T, Bauer JM, Stefanski KJ, Lu Q. Enhanced oral bioavailability of a poorly water soluble drug PNU-91325 by supersaturatable formulations. Drug Dev Ind Pharm. 2004;30:221\u20139.","journal-title":"Drug Dev Ind Pharm"},{"key":"772_CR72","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1208\/s12248-012-9433-7","volume":"15","author":"N Thomas","year":"2012","unstructured":"Thomas N, Holm R, Garmer M, Karlsson JJ, Mullertz A, Rades T. Supersaturated self-nanoemulsifying drug delivery systems (Super-SNEDDS) enhance the bioavailability of the poorly water-soluble drug simvastatin in dogs. AAPS J. 2012;15:219\u201327.","journal-title":"AAPS J"},{"key":"772_CR73","doi-asserted-by":"crossref","first-page":"704","DOI":"10.3109\/1061186X.2010.525652","volume":"18","author":"DB Warren","year":"2010","unstructured":"Warren DB, Benameur H, Porter CJ, Pouton CW. Using polymeric precipitation inhibitors to improve the absorption of poorly water-soluble drugs: a mechanistic basis for utility. J Drug Target. 2010;18:704\u201331.","journal-title":"J Drug Target"},{"key":"772_CR74","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0378-5173(99)00345-2","volume":"193","author":"SL Raghavan","year":"2000","unstructured":"Raghavan SL, Trividic A, Davis AF, Hadgraft J. Effect of cellulose polymers on supersaturation and in vitro membrane transport of hydrocortisone acetate. Int J Pharm. 2000;193:231\u20137.","journal-title":"Int J Pharm"},{"key":"772_CR75","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jconrel.2012.02.027","volume":"160","author":"N Thomas","year":"2012","unstructured":"Thomas N, Holm R, Mullertz A, Rades T. In vitro and in vivo performance of novel supersaturated self-nanoemulsifying drug delivery systems (super-SNEDDS). J Control Release. 2012;160:25\u201332.","journal-title":"J Control Release"},{"key":"772_CR76","first-page":"1029","volume":"35","author":"RC Marques","year":"2009","unstructured":"Marques RC, Cole E, Kruep D, Gray V, Murachanian D, Brown WE, et al. Liquid-filled gelatin capsules. Pharmacopeial Forum. 2009;35:1029\u201341.","journal-title":"Pharmacopeial Forum"},{"key":"772_CR77","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.colsurfb.2012.07.017","volume":"101","author":"B Singh","year":"2013","unstructured":"Singh B, Singh R, Bandyopadhyay S, Kapil R, Garg B. Optimized nanoemulsifying systems with enhanced bioavailability of carvedilol. Colloids Surf B Biointerfaces. 2013;101:465\u201374.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"772_CR78","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/0277-5379(91)90142-Z","volume":"27","author":"YP Keepers","year":"1991","unstructured":"Keepers YP, Pizao PE, Peters GJ, van Ark-Otte J, Winograd B, Pinedo HM. Comparison of the sulforhodamine B protein and tetrazolium (MTT) assays for in vitro chemosensitivity testing. Eur J Cancer Clin Oncol. 1991;27:897\u2013900.","journal-title":"Eur J Cancer Clin Oncol"},{"key":"772_CR79","first-page":"903","volume":"80","author":"N Dhingra","year":"2018","unstructured":"Dhingra N, Kar A, Sharma R. Inhibition of aromatase and cell proliferation of breast cancer and human placenta choriocarcinoma by Prunus persica extracts. IJPS. 2018;80:903\u201310.","journal-title":"IJPS."},{"key":"772_CR80","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v26.i5.10","volume":"26","author":"B Singh","year":"2009","unstructured":"Singh B, Bandopadhyay S, Kapil R, Singh R, Katare OP. Self-emulsifying drug delivery systems (SEDDS): formulation development, characterization, and applications. Crit Rev Ther Drug Carrier Syst. 2009;26:427\u2013521.","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"772_CR81","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0022-5193(88)80123-1","volume":"131","author":"DA Johnson","year":"1988","unstructured":"Johnson DA, Amidon GL. Determination of intrinsic membrane transport parameters from perfused intestine experiments: a boundary layer approach to estimating the aqueous and unbiased membrane permeabilities. J Theor Biol. 1988;131:93\u2013106.","journal-title":"J Theor Biol"},{"key":"772_CR82","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1248\/bpb.31.118","volume":"31","author":"Y Chen","year":"2008","unstructured":"Chen Y, Li G, Wu X, Chen Z, Hang J, Qin B, et al. Self-microemulsifying drug delivery system (SMEDDS) of vinpocetine: formulation development and in vivo assessment. Biol Pharm Bull. 2008;31:118\u201325.","journal-title":"Biol Pharm Bull"},{"key":"772_CR83","first-page":"2445","volume":"6","author":"YM Lin","year":"2011","unstructured":"Lin YM, Wu JY, Chen YC, Su YD, ., Ke WT, Ho HO, Sheu MT In situ formation of nanocrystals from a self-microemulsifying drug delivery system to enhance oral bioavailability of fenofibrate. Int J Nanomedicine 2011;6:2445\u20132457.","journal-title":"Int J Nanomedicine"},{"key":"772_CR84","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ijpharm.2008.08.009","volume":"365","author":"Y Liu","year":"2009","unstructured":"Liu Y, Zhang P, Feng N, Zhang X, Wu S, Zhao J. Optimization and in situ intestinal absorption of self-microemulsifying drug delivery system of oridonin. Int J Pharm. 2009;365:136\u201342.","journal-title":"Int J Pharm"},{"key":"772_CR85","volume-title":"IVIVR versus IVIVC","author":"J Polli","year":"2000","unstructured":"Polli J. IVIVR versus IVIVC. 2000."},{"key":"772_CR86","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/978-1-4684-6036-0_19","volume":"423","author":"S Bigora","year":"1997","unstructured":"Bigora S, Piscitelli D, Dowell J, Butler J, Farrell C, Devane J, et al. Use of nonlinear mixed effects modelling in the development of in vitro-in vivo correlations. Adv Exp Med Biol. 1997;423:207\u201315.","journal-title":"Adv Exp Med Biol"},{"key":"772_CR87","unstructured":"Library C. Saturated solutions and solubility. https:\/\/chem.libretexts.org\/Bookshelves\/General_Chemistry. Acess date Dec 2019."}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-020-00772-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-020-00772-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-020-00772-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T23:37:29Z","timestamp":1621035449000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-020-00772-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,15]]},"references-count":87,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["772"],"URL":"https:\/\/doi.org\/10.1007\/s13346-020-00772-x","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,15]]},"assertion":[{"value":"15 May 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}